Unlocking the Future: Navigating the Next Phase of Biologics through the CDMO Lens

• Explore the pivotal role of Contract Development and Manufacturing Organizations (CDMOs) in the biopharmaceutical industry.
• Gain insights into the trends, challenges, and innovations shaping the next phase of biologics development.
• Discover how CDMOs drive efficiency, ensure quality, and enable scalability in biologics production.
• Stay ahead in the dynamic world of biologics with a focus on the transformative CDMO impact.

 

 

Speakers

Elena Dukhovlinova, Ph.D.

Principal Scientist, Cell & Gene Therapy
Alcami

Dr. Elena Dukhovlinova is a Principal Scientist, Bioassays, leading a team of scientists at Alcami Durham site that focuses on Analytical Development for Cell and Gene Therapies and Biologics. She is a subject matter expert in molecular and cell-based assays with 20+ years of experience from both academia and Big Pharma. Prior to Alcami, she was a CMC Leader and Scientific Integrator at Janssen Cell and Gene Therapy group supporting various stages of drug development for autologous and allogeneic cell therapies and AAV assets. Her academic experience includes research at UNC Chapel Hill and Yale University focused on optimization of CAR T cell therapies, HIV vaccine development and lentiviruses.

 

Will Boomershine

Sr. Manager, Laboratory Operations
Alcami

William Boomershine is a Sr. Manager in Alcami’s Biologics group in Wilmington, NC.  He has over 16 years of experience in the pharmaceutical development and manufacturing industry supporting analytical methods for peptides, proteins, mono-clonal antibodies, oligonucleotides, cell, and gene therapies.

 

Michelle Mayer

Manager, Biostorage
Alcami

Michelle Mayer is the Biorepository Manager for Alcami’s New England locations. Michelle is an accomplished leader with more than 10 years of experience with cGMP storage. She is focused on building high-performing teams to develop strategic relationships with and provide unparalleled customer support to life science companies. Michelle holds an MBA from Southern New Hampshire University.